Preparation and evaluation of [67Ga]-DTPA-β-1-24- corticotrophin in normal rats

Radiochimica Acta

Volumn 96, Issue 7, 2008, Pages 435-439

  Jalilian, A R ^a   Shanehsazzadeh, S ^b   Akhlaghi, M ^a   Garoosi, J ^a   Rajabifar, S ^a   Tavakoli, M B ^b  

^a AGRICULTURAL MEDICAL AND INDUSTRIAL RESEARCH SCHOOL   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

1 24 corticotrophin; DTPA; Gallium 67; Quality control; Radiolabeling

Indexed keywords

EID: 46449118937     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2008.1512     Document Type: Article

References (22)

1. Cone, R. D., Mountjoy, K. G.: Molecular genetics of the ACTH and melanocyte-stimulating hormone receptors. Trends Endocrinol. Metabol. 4, 242 (1993).
2. Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., Cone, R. D.: The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248 (1992).
3. nd Ed. (Felig, P., Baxter, J. D., Broadus, A. E., Frohman, L. A., eds.) McGraw-Hill, New York (1986), pp. 511-692.
4. Slominski, A., Ermak, G., Mihm, M.: ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J. Clin. Endocrinol. Metabol. 81, 2746 (1996).
5. Lin, C. J., Jorge, A. A., Latronico, A. C., Marui, S., Fragoso, M. C., Martin, R. M.: Origin of an ovarian steroid cell tumor causing isosexual pseudo precocious puberty demonstrated by the expression of adrenal steroidogenic enzymes and adrenocorticotropin receptor. J. Clin. Endocrinol. Metabol. 85, 1211 (2000).
6. Boston, B. A., Cone, R. D.: Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology 137, 2043 (1996).
7. Thomas, M., Keramidas, M., Monchaux, E., Feige, J. J.: Role of adrenocorticotropic hormone in the development and maintenance of the adrenal cortical vasculature. Microsc. Res. Tech. 61, 247 (2003).
8. Sewer, M. B., Waterman, M. R.: ACTH modulation of transcription factors responsible for steroid hydroxylase gene expression in the adrenal cortex. Microsc. Res. Tech. 61, 300 (2003).
9. Dallman, M. F., la Fleur, S. E., Pecoraro, N. C., Gomez, F., Houshyar, H., Akana, S. F.: Minireview: glucocorticoids - food intake, abdominal obesity, and wealthy nations in 2004. Endocrinol. 145, 2633 (2004).
10. Zwermann, O., Schulte, D. M., Reincke, M., Beuschlein, F.: ACTH 1-24 inhibits proliferation of adrenocortical tumors in vivo. Eur. J. Endocrinol. 153(3), 435 (2005).
11. 201Tl](III)-DTPA-human polyclonal antibody complex for inflammation detection. Radiochim. Acta 95, 669 (2007).
12. 67Ga]-DTPA-rituximab in normal rats. J. Radioanal. Nucl. Chem. 274, 175 (2007).
13. 64Cu]-DOTA-anti-CD20 for targeted therapy. J. Radioanal. Nucl. Chem. 274, 563 (2007).
14. Daube-Whiterspoon, M. E., Green, S. L., Plascjak, P., Wu, C., Carson, E., Eckelman, W. C.: PET imaging characteristics of Ga-66. J. Nucl. Med. 38, 200 (1997).
15. Lewis, M. R., Reichert, D. E., Laforest, R., Margenau, W. H., Shefer, R. E., Klinkowstein, R. E., Hughey, B. J., Welch, M. J.: Production and purification of gallium-66 for preparation of tumor-targeting radiopharmaceuticals. Nucl. Med. Biol. 29, 701 (2002).
16. 66Ga as an isotope for PET imaging and quantification. Med. Phys. 24, 317 (1997).
17. th Edn., John Wiley & Sons Inc., New York (1996).
18. 66Ga - a promising isotope for positron emission tomography. Acta Radiol. Suppl. 37, 60 (1991).
19. 66Ga radionuclide. Nukleonika 51, 147 (2006).
20. 177Lu-DOTA- lanreotide: A novel tracer as a targeted agent for tumor therapy. Nucl. Med. Biol. 31, 753 (2004).
21. SYNACTHEN DEPOT®. Data Sheet, Novartis New Zealand Limited, Private Bag 47909 Ponsonby, 6-8 Mackelvie Street, Grey Lynn, Auckland, 15 Feb. (2006).
22. Herring, K., Sandberg, D.: Tumor marker control. U.S. Patent No. 5,747,268, May 5 (1998).